Correlation Between Apogee Therapeutics, and 90331HPL1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and 90331HPL1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and 90331HPL1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and US BANK NATIONAL, you can compare the effects of market volatilities on Apogee Therapeutics, and 90331HPL1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of 90331HPL1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and 90331HPL1.

Diversification Opportunities for Apogee Therapeutics, and 90331HPL1

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Apogee and 90331HPL1 is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and US BANK NATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US BANK NATIONAL and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with 90331HPL1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US BANK NATIONAL has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and 90331HPL1 go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and 90331HPL1

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the 90331HPL1. In addition to that, Apogee Therapeutics, is 2.25 times more volatile than US BANK NATIONAL. It trades about -0.16 of its total potential returns per unit of risk. US BANK NATIONAL is currently generating about -0.32 per unit of volatility. If you would invest  9,989  in US BANK NATIONAL on November 6, 2024 and sell it today you would lose (446.00) from holding US BANK NATIONAL or give up 4.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy31.58%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  US BANK NATIONAL

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
US BANK NATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for US BANK NATIONAL investors.

Apogee Therapeutics, and 90331HPL1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and 90331HPL1

The main advantage of trading using opposite Apogee Therapeutics, and 90331HPL1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, 90331HPL1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90331HPL1 will offset losses from the drop in 90331HPL1's long position.
The idea behind Apogee Therapeutics, Common and US BANK NATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume